Biotricity Net Income from 2010 to 2026

BTCY Stock  USD 0.31  0.01  3.13%   
Biotricity Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss will likely drop to about -8 M in 2026. During the period from 2010 to 2026, Biotricity Net Loss regression line of annual values had significance of  0.01 and arithmetic mean of (8,510,853). View All Fundamentals
 
Net Loss  
First Reported
2014-03-31
Previous Quarter
-672 K
Current Value
-690.9 K
Quarterly Volatility
M
 
Yuan Drop
 
Covid
Check Biotricity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biotricity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.1 K, Interest Expense of 6.3 M or Selling General Administrative of 9.8 M, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0035 or Days Sales Outstanding of 141. Biotricity financial statements analysis is a perfect complement when working with Biotricity Valuation or Volatility modules.
  
Build AI portfolio with Biotricity Stock
Check out the analysis of Biotricity Correlation against competitors.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

Latest Biotricity's Net Income Growth Pattern

Below is the plot of the Net Income of Biotricity over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Biotricity financial statement analysis. It represents the amount of money remaining after all of Biotricity operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Biotricity's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biotricity's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (8.42 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Biotricity Net Income Regression Statistics

Arithmetic Mean(8,510,853)
Coefficient Of Variation(90.88)
Mean Deviation5,421,276
Median(7,958,014)
Standard Deviation7,734,424
Sample Variance59.8T
Range29M
R-Value(0.63)
Mean Square Error38.6T
R-Squared0.40
Significance0.01
Slope(962,700)
Total Sum of Squares957.1T

Biotricity Net Income History

2026-8 M
2025-7.6 M
2024-8.4 M
2023-14.1 M
2022-18.7 M
2021-29.1 M
2020-15.5 M

Other Fundumenentals of Biotricity

About Biotricity Financial Statements

Biotricity investors use historical fundamental indicators, such as Biotricity's Net Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biotricity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-7.6 M-8 M
Net Loss-7.6 M-8 M
Net Loss-27.2 M-25.8 M
Net Loss(1.42)(1.50)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biotricity Stock Analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.